Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”Marc‐Oliver Grimm, Tim Muilwijk, Luis Martínez‐Piñeiro et al.|European Urology|2020Cited by 132
POSC399 Treatment Effect and Costs of the Complete Therapeutic Pathway in Patients with First-Line Castration-Resistant Prostate Cancer with Either First-Line Docetaxel or Abiraterone Acetate Plus PrednisoneMS Holleman, CA Uyl‐de Groot, Ivan Santi et al.|Value in Health|2022Cited by 0